Rujipas SirijatuphatVisanu ThamlikitkulMahidol University2018-11-092018-11-092014-01-01Antimicrobial Agents and Chemotherapy. Vol.58, No.9 (2014), 5598-560110986596006648042-s2.0-84906080468https://repository.li.mahidol.ac.th/handle/20.500.14594/34603Ninety-four patients infected with carbapenem-resistant Acinetobacter baumannii were randomized to receive colistin alone or colistin plus fosfomycin for 7 to 14 days. The patients who received combination therapy had a significantly more favorable microbiological response and a trend toward more favorable clinical outcomes and lower mortality than those who received colistin alone. (This study has been registered at ClinicalTrials.gov under registration no. NCT01297894.) Copyright © 2014, American Society for Microbiology. All Rights Reserved.Mahidol UniversityMedicinePharmacology, Toxicology and PharmaceuticsArticleSCOPUS10.1128/AAC.02435-13